aTYR PHARMA ATYR
NASDAQ ATYR
$0.18 +0.00 (+1.92%)
As of: Oct 22, 2026 · 1:01 PM EDT

aTYR PHARMA (ATYR) EBT Margin (2019 - 2025)

Updated

aTYR PHARMA's EBT Margin was -40856.32% in FY2025, down 11956.74 percentage points from -28899.57% in FY2024.

Analysis

aTYR PHARMA (ATYR) EBT Margin (2019 - 2025) Analysis & Trends

From FY2019 onward, aTYR PHARMA has reported EBT Margin for 6 years.

  • EBT Margin has now declined for three consecutive years, with a five-year change of -40704.13 percentage points (FY2020 to FY2025).
  • The FY2025 figure marks the lowest annual EBT Margin in data going back to FY2019.
  • Per Business Quant data, EBT Margin in earlier years was -28899.57% in FY2024 (-13341.78 pp), -15557.79% in FY2023 (-15111.00 pp) and -446.79% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,171.37 Bn 1,139.96 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 645.23 Bn 565.09 Bn 17.30 Bn 0.13%
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn 25.18%
4 Merck 361.34 Bn 315.71 Bn 12.21 Bn -4.11%
5 Novartis Ag 302.82 Bn 266.81 Bn 11.24 Bn 29.63%
6 Astrazeneca 267.91 Bn 241.60 Bn 12.86 Bn 18.19%
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn 27.53%
8 Gilead Sciences 193.55 Bn 167.74 Bn 6.22 Bn -131.41%
9 Pfizer 172.05 Bn 118.70 Bn 10.94 Bn -4.34%
10 aTYR PHARMA 17.19 Mn -275.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -14,076.32%
Mar 31, 2024 -7,079.15%
Sep 30, 2023 -3,573.65%
Dec 31, 2022 -76.55%
Dec 31, 2020 -240.62%
Sep 30, 2020 -4,400.00%
Jun 30, 2020 -3,342.86%
Mar 31, 2020 23.05%
Dec 31, 2019 -4,140.28%
Sep 30, 2019 -2,988.04%
Jun 30, 2019 -6,001.06%
API Access

aTYR PHARMA EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ATYR&period=max&api_key=YOUR_API_KEY